We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Jefferies' (JEF) Q3 Earnings Lag Estimates as Costs Rise
Read MoreHide Full Article
Jefferies Financial Group Inc.’s (JEF - Free Report) earnings per share for the three-month period ended Aug 31, 2019, of 15 cents lagged the Zacks Consensus Estimate of 42 cents. Further, the figure compared unfavorably with earnings of 55 cents per share recorded in the three-month period ended Sep 30, 2018.
The company’s results were adversely impacted by a decline in revenues and higher expenses. Both the Merchant Banking segment and Jefferies Group’s performance was relatively weak in the reported quarter when compared with the prior-year quarter. However, the Corporate segment’s performance remained decent.
Net income attributable to shareholders for the three months ended Aug 31, 2019, was $48.5 million, down from $192.6 million recorded in the three months ended Sep 30, 2018.
Revenues Decline, Expenses Rise
Net revenues for the reported quarter were $856.8 million, down from $1.15 billion recorded in the three months ended Sep 30, 2018. The figure lagged the Zacks Consensus Estimate of $1.07 billion.
Total expenses were $915.8 million, up from $897 million reported in the third quarter of 2018. This increase can be attributed to a rise in almost all expense components except compensation and benefits costs, and interest expenses.
Segmental Information
Jefferies Group: This segment reported net revenues of $777.2 million in the three months ended Aug 31, 2019, marginally down from $777.6 million recorded in the three months ended Sep 30, 2018. Expenses were $694.1 million, up from $690.5 million recorded in the third quarter of 2018.
Merchant Banking: Net revenues were $75.5 million in the three months ended Aug 31, 2019, down from $369.3 million recorded in the three months ended Sep 30, 2018. Expenses were $190.7 million, up from $169.6 million recorded in the three-month period ended Sep 30, 2018.
Corporate: This segment reported net revenues of $9 million, up from $8.7 million recorded in the three months ended Sep 30, 2018. Expenses were $20.7 million, down from $24.1 million recorded in the third quarter of 2018.
Our Viewpoint
Jefferies is a geographically diversified company, with presence in almost all the major global markets. Consequently, risks stemming from geographical diversification might hurt financials. Moreover, elevated costs are likely to hurt profits. Nevertheless, supported by a solid capital position, Jefferies is expected to continue enhancing shareholder value through efficient capital deployment activities.
JEFFERIES FINANCIAL GROUP INC. Price, Consensus and EPS Surprise
Among the other finance companies, JPMorgan Chase (JPM - Free Report) and Citigroup (C - Free Report) are expected to report quarterly results on Oct 15. The Bank of New York Mellon Corp. (BK - Free Report) is expected to report numbers the next day.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Jefferies' (JEF) Q3 Earnings Lag Estimates as Costs Rise
Jefferies Financial Group Inc.’s (JEF - Free Report) earnings per share for the three-month period ended Aug 31, 2019, of 15 cents lagged the Zacks Consensus Estimate of 42 cents. Further, the figure compared unfavorably with earnings of 55 cents per share recorded in the three-month period ended Sep 30, 2018.
The company’s results were adversely impacted by a decline in revenues and higher expenses. Both the Merchant Banking segment and Jefferies Group’s performance was relatively weak in the reported quarter when compared with the prior-year quarter. However, the Corporate segment’s performance remained decent.
Net income attributable to shareholders for the three months ended Aug 31, 2019, was $48.5 million, down from $192.6 million recorded in the three months ended Sep 30, 2018.
Revenues Decline, Expenses Rise
Net revenues for the reported quarter were $856.8 million, down from $1.15 billion recorded in the three months ended Sep 30, 2018. The figure lagged the Zacks Consensus Estimate of $1.07 billion.
Total expenses were $915.8 million, up from $897 million reported in the third quarter of 2018. This increase can be attributed to a rise in almost all expense components except compensation and benefits costs, and interest expenses.
Segmental Information
Jefferies Group: This segment reported net revenues of $777.2 million in the three months ended Aug 31, 2019, marginally down from $777.6 million recorded in the three months ended Sep 30, 2018. Expenses were $694.1 million, up from $690.5 million recorded in the third quarter of 2018.
Merchant Banking: Net revenues were $75.5 million in the three months ended Aug 31, 2019, down from $369.3 million recorded in the three months ended Sep 30, 2018. Expenses were $190.7 million, up from $169.6 million recorded in the three-month period ended Sep 30, 2018.
Corporate: This segment reported net revenues of $9 million, up from $8.7 million recorded in the three months ended Sep 30, 2018. Expenses were $20.7 million, down from $24.1 million recorded in the third quarter of 2018.
Our Viewpoint
Jefferies is a geographically diversified company, with presence in almost all the major global markets. Consequently, risks stemming from geographical diversification might hurt financials. Moreover, elevated costs are likely to hurt profits. Nevertheless, supported by a solid capital position, Jefferies is expected to continue enhancing shareholder value through efficient capital deployment activities.
JEFFERIES FINANCIAL GROUP INC. Price, Consensus and EPS Surprise
JEFFERIES FINANCIAL GROUP INC. price-consensus-eps-surprise-chart | JEFFERIES FINANCIAL GROUP INC. Quote
Currently, the company carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Among the other finance companies, JPMorgan Chase (JPM - Free Report) and Citigroup (C - Free Report) are expected to report quarterly results on Oct 15. The Bank of New York Mellon Corp. (BK - Free Report) is expected to report numbers the next day.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>